GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: MBX2319 is a novel pyranopyridine compound that acts as a bacterial efflux pump inhibitor (EPI). It has potent activity against the resistance-nodulation-division (RND) family of efflux pumps of Enterobacteriaceae [1], binding to AcrB, a component of the AcrAB-TolC efflux pump [2-3]. EPIs have potential clinical utility as adjunctive therapeutic agents for the treatment of infections caused by Gram-negative pathogens.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| MBX2319 does not have intrinsic antibacterial activity, however it decreases the MIC of ciprofloxacin, levofloxacin, and piperacillin against Escherichia coli [1]. |